Blind Loop Syndrome clinical trials
The registry lists 11 studies for Blind Loop Syndrome across 7 countries. 4 are recruiting or about to start. 9 of them are mainly about Blind Loop Syndrome (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-15.
Get an email when these change. Save the Blind Loop Syndrome studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Erasme University Hospital (1) · Johns Hopkins University (1) · Lille Catholic University (1) · Warsaw University of Life Sciences (1) · Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji (1) · National University of Natural Medicine (1) · Shandong University (1) · Northwestern University (1)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 3
- Jul 2027Effect of Multispecies Probiotic Supplementation on the Efficacy of Rifaximin α Therapy in Patients With Small Intestinal Bacterial Overgrowth (SIBO): a Randomized Placebo-controlled Trial · Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji
- Aug 2027Evaluation of the Performance of MAgnetic Gastrointestinal Universal Septotome for Treatment of Candy Cane Syndrome · Erasme University Hospital
- Nov 2027Comparison of the Efficacy of Saccharomyces Boulardii and Rifaximin in the Treatment of Small Intestinal Bacterial Overgrowth · Shandong University
Who these studies take
Of the 2 Blind Loop Syndrome studies recruiting now, 1 (50%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 2 (100%) | 2 (100%) |
| 30 | 2 (100%) | 2 (100%) |
| 40 | 2 (100%) | 2 (100%) |
| 50 | 2 (100%) | 2 (100%) |
| 65 | 2 (100%) | 2 (100%) |
| 75 | 2 (100%) | 2 (100%) |
| 85 | 2 (100%) | 2 (100%) |
Across all 11 studies, recruiting or not: 36% stop at 75 or younger and 9% at 65; 9% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 11 of 11. search them.
- Comparison of the Efficacy of Saccharomyces Boulardii and Rifaximin in the Treatment of Small Intestinal Bacterial OvergrowthNot yet recruitingNCT07815548Phase 41 country
- Effect of Multispecies Probiotic Supplementation on the Efficacy of Rifaximin α Therapy in Patients With Small Intestinal Bacterial Overgrowth (SIBO): a Randomized Placebo-controlled TrialNot yet recruitingNCT07426705Phase 4
- Herbal Evaluation Of Artemisia Annua For Small Intestinal Bacterial OvergrowthRecruitingNCT06721884Phase 1/21 country
- Evaluation of the Performance of MAgnetic Gastrointestinal Universal Septotome for Treatment of Candy Cane SyndromeRecruitingNCT05938439Not applicable1 country
- The Low FODMAP Diet in Individuals With Small Intestinal Bacterial Overgrowth (SIBO)CompletedNCT07424313Not applicable1 country
- Small Intestinal Bacterial Overgrowth ObeseCompletedNCT02819037Not applicable1 country
- Clinical Utility of Handheld Hydrogen Breathalyzer in Identification of Food Sensitivities (AIRE Study)CompletedNCT04309396Not applicable1 country
- Atrantil for Intestinal Bacterial OvergrowthCompletedNCT04755673Not applicable1 country
- Primary Prophylaxis for Spontaneous Bacterial PeritonitisTerminatedNCT04775329Phase 2/31 country
- Retrospective Analysis of Treatment Outcomes in Patients With Bacterial Overgrowth Syndrome Diagnosed by D-Xylose Breath TestingCompletedNCT013248951 country
- Comparison Between Erythromycin and Neomycin Treatment of Hepatic EncephalopathyStatus unknownNCT01097811Not applicable1 country